T1	Outcomes 335 383	the pharmacokinetic interaction and tolerability
T2	Outcomes 802 839	interval of the AUC0-48 h geometric
T3	Outcomes 1040 1053	(0.50, 2.00).
T4	Outcomes 1054 1092	4. Exposures to simvastatin acid and
T5	Outcomes 1307 1327	these TCMs were well
